| Primary |
| Acute Coronary Syndrome |
23.2% |
| Product Used For Unknown Indication |
15.9% |
| Prophylaxis |
11.6% |
| Gastritis |
5.8% |
| Gastrooesophageal Reflux Disease |
5.8% |
| Helicobacter Gastritis |
4.3% |
| Helicobacter Infection |
4.3% |
| Pulmonary Embolism |
4.3% |
| Hypertension |
2.9% |
| Immunosuppression |
2.9% |
| Intentional Self-injury |
2.9% |
| Nausea |
2.9% |
| Ulcer |
2.9% |
| Abdominal Pain Upper |
1.4% |
| Anaemia |
1.4% |
| Antacid Therapy |
1.4% |
| Diabetes Mellitus |
1.4% |
| Dyspepsia |
1.4% |
| Eye Inflammation |
1.4% |
| Gastric Mucosal Lesion |
1.4% |
|
| Cutaneous Lupus Erythematosus |
12.0% |
| Hypomagnesaemia |
12.0% |
| Visual Impairment |
8.0% |
| Abnormal Sensation In Eye |
4.0% |
| Angina Pectoris |
4.0% |
| Atrial Fibrillation |
4.0% |
| Chromaturia |
4.0% |
| Clostridium Test Positive |
4.0% |
| Death |
4.0% |
| Face Oedema |
4.0% |
| Hypersensitivity |
4.0% |
| Hypertension |
4.0% |
| Hyperuricaemia |
4.0% |
| Intentional Overdose |
4.0% |
| Irritability |
4.0% |
| Myocardial Infarction |
4.0% |
| Off Label Use |
4.0% |
| Percutaneous Coronary Intervention |
4.0% |
| Suicidal Ideation |
4.0% |
| Swelling Face |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
49.0% |
| Pyrexia |
16.2% |
| Hypovitaminosis |
9.2% |
| Acute Coronary Syndrome |
5.6% |
| Prophylaxis |
3.1% |
| Abdominal Pain |
2.5% |
| Drug Use For Unknown Indication |
2.5% |
| Gastric Ulcer |
2.5% |
| Gerd |
1.1% |
| Hiatal Hernia |
1.1% |
| Hypertension |
1.1% |
| Crohn's Disease |
0.8% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Helicobacter Infection |
0.8% |
| Myelofibrosis |
0.8% |
| Constipation |
0.6% |
| Dependence |
0.6% |
| Gastritis |
0.6% |
| Infection |
0.6% |
| Nausea |
0.6% |
|
| Pain In Extremity |
17.1% |
| Toxic Epidermal Necrolysis |
9.8% |
| Vaginal Discharge |
9.8% |
| Hypertension |
7.3% |
| Neuroendocrine Tumour |
7.3% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
4.9% |
| Myocardial Infarction |
4.9% |
| Paraesthesia |
4.9% |
| Renal Failure Acute |
4.9% |
| Tremor |
4.9% |
| Angina Pectoris |
2.4% |
| Death |
2.4% |
| Dysgeusia |
2.4% |
| Fatigue |
2.4% |
| Gastrointestinal Haemorrhage |
2.4% |
| Herpes Zoster |
2.4% |
| Hospitalisation |
2.4% |
| Hypomagnesaemia |
2.4% |
| Intentional Overdose |
2.4% |
| Pancreatitis |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.5% |
| Surgery |
12.8% |
| Prophylaxis |
6.8% |
| Hypertension |
6.3% |
| Rheumatoid Arthritis |
5.0% |
| Crohn's Disease |
4.8% |
| Medical Diet |
4.1% |
| Abdominal Pain |
4.0% |
| Drug Use For Unknown Indication |
4.0% |
| Oesophagitis |
3.3% |
| Premedication |
2.7% |
| Diffuse Large B-cell Lymphoma |
1.9% |
| Pain |
1.9% |
| Gastritis |
1.5% |
| Diabetes Mellitus |
1.5% |
| Hepatic Neoplasm Malignant |
1.4% |
| Hypoalbuminaemia |
1.3% |
| Nuclear Magnetic Resonance Imaging |
1.3% |
| Dyspepsia |
0.9% |
| Depression |
0.9% |
|
| Vomiting |
14.4% |
| Death |
10.1% |
| Weight Decreased |
9.4% |
| Abdominal Pain |
7.9% |
| Urinary Tract Infection |
7.6% |
| Myocardial Infarction |
6.8% |
| Weight Increased |
5.8% |
| Pneumonia |
4.7% |
| Tachycardia |
4.3% |
| Thrombocytopenia |
4.3% |
| Hepatic Failure |
2.9% |
| Pulmonary Embolism |
2.9% |
| Rheumatoid Arthritis |
2.9% |
| Nausea |
2.5% |
| Respiratory Failure |
2.5% |
| White Blood Cell Count Decreased |
2.5% |
| Fall |
2.2% |
| Nephrolithiasis |
2.2% |
| Pruritus |
2.2% |
| Renal Failure |
2.2% |
|
